Live Breaking News & Updates on Breakthroughs that change patient

Stay informed with the latest breaking news from Breakthroughs that change patient on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Breakthroughs that change patient and stay connected to the pulse of your community

Pfizer Declares Second-Quarter 2024 Dividend

Board of Directors approves quarterly cash dividend of $0.42 per share

...

Pfizer-inc , Pfizer , Youtube , Linkedin , Common-stock , Breakthroughs-that-change-patient , Pfizer-news , Markets ,

European Commission Approves Pfizer's EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options

European Commission Approves Pfizer's EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Iceland , Norway , Canada , Boston , Massachusetts , United-states , Treasure-island , Liechtenstein , Tel-aviv , Israel , Yehuda-carmeli , Antimicrob-chemother

Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25

Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Youtube , Pfizer , Exchange-commission , Pfizer-inc , Linkedin , Annual-meeting , Breakthroughs-that-change-patient , Pfizer-news , Annual-report , Looking-information , Factors-that-may-affect-future

Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease

Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Australia , Argentina , Macau , Canada , Japan , Annaliesa-anderson , Finkd-immunobridging , Alimentosy-tecnolog , Forum-infect-dis , Health-canada , Centers-for-disease

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease

NEW YORK, March 13, 2024--Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20®, for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age.

Espa , Hordaland , Norway , Brazil , Australia , Canada , Liechtenstein , Spain , United-states , Iceland , Italy , Lichtenstein

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease -March 13, 2024 at 04:03 am EDT

PREVENAR 20® offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of...

Espa , Hordaland , Norway , Spain , Liechtenstein , Brazil , Canada , Australia , Italy , United-states , Iceland , Lichtenstein

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease | Nation/World

NEW YORK--(BUSINESS WIRE)--Mar 13, 2024--

Espa , Hordaland , Norway , Brazil , Australia , Liechtenstein , Spain , Iceland , Italy , United-states , Canada , Lichtenstein

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease | Region

NEW YORK--(BUSINESS WIRE)--Mar 13, 2024--

Espa , Hordaland , Norway , United-states , Brazil , Liechtenstein , Iceland , Canada , Australia , Italy , Spain , Lichtenstein

Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

ECHELON-3 trial of ADCETRIS in combination with lenalidomide and rituximab showed significant improvement in primary endpoint of overall survival and in secondary endpoints of progression free...

Japan , Canada , United-states , America , Canadian , American , Roger-dansey , Drug-administration , Exchange-commission , Youtube , Linkedin , Pfizer

Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults

ABRYSVO, a bivalent vaccine, maintained consistently high protective efficacy for both RSV A and RSV B disease through two seasons after a single dose.

ABRYSVO efficacy was 77.8% against RSV...

United-states , Japan , Argentina , Macau , Canada , Alimentosy-tecnolog , Annaliesa-anderson , Pfizer , Administration-bureau-of-macau , Vaccine-research , Health-canada , Regulatory-agency